945 Promoter Hypermethylation of a Novel Tumor Suppressor Gene CA4 Associated with Colon Cancer Recurrence

Jingwan Zhang,Xiaoxing Li,Jia Wang,Jing Gao,Minnie Y. Go,Joseph J. Y. Sung,Jun Yu

DOI: https://doi.org/10.1016/s0016-5085(14)60587-4

IF: 29.4

2014-01-01

Gastroenterology

Abstract:significantly associated with age at diagnosis, age at surgery and disease duration in the rectal tissues.In contrast, no associations were observed between miR-34b/c methylation levels and any of the clinicopathological factors.Methylation levels of all 5 miRNAs were significantly higher in neoplasia (dysplasia and cancer) compared to non-neoplastic tissues.In addition, the methylation levels of all 5 miRNAs in rectal specimens were significantly higher in patients with cancer than in those without it, suggesting the presence of a "field defect" in the rectal tissues of UC patients.Receiver operating characteristics (ROC) analysis revealed that methylation levels of all 5 miRNAs in non-neoplastic rectal tissues successfully discriminated between patients with cancer from those without it.More importantly, the methylation status of miR-137 in non-neoplastic rectal tissues distinguished UC patients with and without neoplasia (AUC = 0.77), and emerged as an independent predictor of neoplasia (OR: 5.66; 95% CI: 1.37-23.47;P = 0.0168).Conclusions: The methylation levels of miR-1,-9, -124 and -137 displayed an age-and cancer-related pattern and indicated existence of a "field defect" in patients with UC.Methylation of these miRNAs in rectal biopsies-particularly miR-137-may potentially be a clinically-relevant biomarker for identifying patients at high risk for developing ulcerative colitis.